PF-Atlas › Clinical Trials › NCT03855722
Remote Ischaemic Preconditioning in Transplantation
RIPC · Not specified
Registry ID
NCT03855722
Phase
Not specified
Status
Recruiting
Drug / intervention
RIPC
Sponsor
Helsinki University Central Hospital
Start
2019-03-12
Enrollment
496
Locations
1
About this trial
Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in animal models and heart surgery, but it's benefit in transplantation has been studied less. The primary aim of this study is to find out whether RIPC performed in a donor in donation after brain-death (DBD) could improve delayed graft function rate of kidney transplants.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03855722 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.